Abstract |
In a preliminary open prospective study ketoconazole ( Nizoral; Janssen) 200 mg twice daily for 5 consecutive days was found to be extremely effective in treating vulvovaginal candidiasis, producing cure rates of 96% at 7 days and 92% at 28 days. The oral route of administration has definite advantages over the vaginal route and improves patient compliance. No side-effects related to treatment were found in this study.
|
Authors | B Bloch, E Smythe |
Journal | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
(S Afr Med J)
Vol. 67
Issue 5
Pg. 178-9
(Feb 02 1985)
ISSN: 0256-9574 [Print] South Africa |
PMID | 3983757
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Administration, Oral
- Adult
- Candidiasis, Vulvovaginal
(drug therapy)
- Female
- Humans
- Ketoconazole
(administration & dosage, therapeutic use)
- Pilot Projects
- Prospective Studies
|